We are studying whether the immunotherapy Cemiplimab can help prevent cancer recurrence in patients with high-risk stage III/IV skin cancer who can undergo surgery.
Health conditions and diseases that the clinical trial is designed to study and treat.
Cutaneous Squamous Cell Carcinoma (CSCC) is a type of skin cancer that arises from squamous cells, which are flat cells found in the outer layer of the skin. It can appear as a growth or sore that doesn't heal and may be more aggressive in advanced stages.
Surgically resectable, high risk Stage III/IV Cutaneous Squamous Cell Carcinoma refers to advanced skin cancer that can still be surgically removed. This stage indicates a higher risk of recurrence and may require additional treatments.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.